Results 61 to 70 of about 11,990 (130)

Efficacy and factors associated with reactivation following intravitreal ranibizumab or conbercept for retinopathy of prematurity. [PDF]

Front Med (Lausanne)
Liu Q, Li J, Liu J, Xie S, Mu G, Zhao H, Zheng J, Huang X, Wang J.   +8 more
europepmc   +1 more source

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Comparison of the clinical effect of intravitreal ranibizumab and intravitreal dexamethasone implants in the treatment of retinal vein occlusion complicated with macular oedema: a meta-analysis. [PDF]

BMC Ophthalmol
Li Y, Hu L, Zu J.
europepmc   +1 more source

Effects of Subconjunctival Bevacizumab and Ranibizumab on Corneal and Systemic Oxidative Stress Biomarkers in an Alkali Injury Model. [PDF]

Life (Basel)
Yarbağ A, Bardaş Özkan E, Ulaş M, Arslan YK.   +3 more
europepmc   +1 more source

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy. [PDF]

Pharmacotherapy
Clements JN, Mesawich J, Twisdale C.
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source

<i>In Silico</i> Design and Analysis of a Novel Ranibizumab-derived Peptide against the Vascular Endothelial Growth Factor. [PDF]

J Ophthalmic Vis Res
Afarid M, Baghban R, Ghasemali S, Zamani J, Zareei A.   +4 more
europepmc   +1 more source

U.S. trends of anti-vascular endothelial growth factor use from 2017-2023: An analysis of medicare, medicaid, and commercial insurance. [PDF]

PLoS One
Malhotra K, Colcombe J, Patil S, Vail D, Parikh R.   +4 more
europepmc   +1 more source

Endophthalmitis Caused by α-Streptococcal Following Intravitreal Ranibizumab Biosimilar Administration Using a Prefilled Syringe. [PDF]

Cureus
Utsunomiya K, Sakurada Y, Kasai H, Tanaka A, Kashiwagi K.   +4 more
europepmc   +1 more source

Anti-VEGF versus laser therapy for retinopathy of prematurity: a systematic review and meta-analysis focusing on recurrence patterns and retreatment needs. [PDF]

Int J Retina Vitreous
Krungkraipetch L, Krungkraipetch D, Krungkraipetch K.   +2 more
europepmc   +1 more source